Publications by authors named "William Blum"

100Publications

Treating acute myeloid leukemia in the modern era: A primer.

Cancer 2020 Aug 7. Epub 2020 Aug 7.

Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32904DOI Listing
August 2020

Phase I study of AR-42 and decitabine in acute myeloid leukemia.

Leuk Lymphoma 2020 06 8;61(6):1484-1492. Epub 2020 Feb 8.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1719095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375689PMC
June 2020

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

N Engl J Med 2019 04;380(17):1628-1637

From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1815105DOI Listing
April 2019

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.

Br J Clin Pharmacol 2019 05 27;85(5):924-934. Epub 2019 Feb 27.

Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475687PMC
May 2019

Progress in the problem of relapsed or refractory acute myeloid leukemia.

Curr Opin Hematol 2019 03;26(2):88-95

Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000490DOI Listing
March 2019

Making the most of hypomethylating agents in myelodysplastic syndrome.

Curr Opin Hematol 2017 03;24(2):79-88

Division of Hematology, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000317DOI Listing
March 2017

Why the stagnation in effective therapy for MDS?

Authors:
William Blum

Best Pract Res Clin Haematol 2016 12 19;29(4):334-340. Epub 2016 Oct 19.

Division of Hematology, The Ohio State University, 320 West 10th Avenue, B312 Starling Loving Hall, Columbus, OH 43210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.10.007DOI Listing
December 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

J Clin Oncol 2015 Dec 2;33(35):4167-75. Epub 2015 Nov 2.

Steven M. Devine and William Blum, Ohio State University, Columbus, OH; Kouros Owzar, Flora Mulkey, Vera Hars, and Alexander B. Sibley, Alliance Statistics and Data Center, Duke University, Durham; Thomas C. Shea, University of North Carolina, Chapel Hill, NC; Richard M. Stone, Robert J. Soiffer, and Edwin P. Alyea, Dana-Farber Cancer Institute; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Jack W. Hsu, University of Florida, Gainesville, FL; Richard E. Champlin, MD Anderson Cancer Research Center, Houston, TX; Ravi Vij, Washington University, St. Louis, MO; James Slack, Mayo Clinic, Scottsdale, AZ; Richard A. Larson, University of Chicago, Chicago, IL; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Shelly Carter, The EMMES Corporation, Bethesda, MD; Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; and Charles Linker, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658453PMC
December 2015

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

Novel therapies in AML: reason for hope or just hype?

Am Soc Clin Oncol Educ Book 2014 :e341-51

From the Division of Hematology, Department of Medicine, Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e341DOI Listing
December 2015

Cancer immunology, success without sequencing.

Authors:
William Blum

J Natl Compr Canc Netw 2014 Mar;12(3):443-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0044DOI Listing
March 2014

Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults.

Br J Haematol 2013 May 23;161(3):406-10. Epub 2013 Feb 23.

Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 452229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12268DOI Listing
May 2013

Emerging immunotherapies in older adults with acute myeloid leukemia.

Curr Opin Hematol 2013 Mar;20(2):107-14

Division of Hematology, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32835d8101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083702PMC
March 2013

Hypomethylating agents in myelodysplastic syndromes.

Authors:
William G Blum

Clin Adv Hematol Oncol 2011 Feb;9(2):123, 126-8

College of Medicine, The Ohio State University, Comprehensive Cancer Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
February 2011

How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.

Authors:
William Blum

Hematology Am Soc Hematol Educ Program 2010 ;2010:314-21

Division of Hematology, Department of Medicine, The Ohio State University and Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2010.1.314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169168PMC
April 2011

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.

Haematologica 2010 Jul 11;95(7):1098-105. Epub 2010 May 11.

Division of Hematology and Oncology and the Comprehensive Cancer Center, Department of Medicine, The Ohio State University, B310 Starling-Loving Hall, 320 West 10 Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.017103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895033PMC
July 2010

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.

Biol Blood Marrow Transplant 2009 May 9;15(5):547-53. Epub 2009 Mar 9.

Hematology and Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953134PMC
May 2009

A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.

Pharm Res 2009 Jun 17;26(6):1504-15. Epub 2009 Mar 17.

College of Pharmacy, The Ohio State University, 500 W. 12th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-009-9863-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071250PMC
June 2009

Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.

Blood 2009 Jan 29;113(5):1002-5. Epub 2008 Sep 29.

Department of Internal Medicine, Division of Oncology, Siteman Cancer Center, Washington University, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-04-152678DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947363PMC
January 2009

Epigenetics in acute myeloid leukemia.

Semin Oncol 2008 Aug;35(4):378-87

German Cancer Research Center, Division of Toxicology and Cancer Risk Factors, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2008.04.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463865PMC
August 2008

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.

J Clin Invest 2008 Jul;118(7):2427-37

Institute of Cancer, Centre for Medical Oncology, Barts and The London School of Medicine, University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/35017
Publisher Site
http://dx.doi.org/10.1172/JCI35017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423865PMC
July 2008

Post-remission therapy in acute myeloid leukemia: what should I do now?

Authors:
William Blum

Haematologica 2008 Jun;93(6):801-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13226DOI Listing
June 2008

New approaches in acute myeloid leukemia.

Best Pract Res Clin Haematol 2008 Mar;21(1):29-41

Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2007.11.009DOI Listing
March 2008

Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality.

Cancer 2007 Jul;110(1):96-102

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22777
Publisher Site
http://dx.doi.org/10.1002/cncr.22777DOI Listing
July 2007

Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.

Semin Thromb Hemost 2007 Jun;33(4):350-4

Department of Internal Medicine, Division of Hematology/Oncology, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2007-976170DOI Listing
June 2007

Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS.

J Chromatogr B Analyt Technol Biomed Life Sci 2007 May 4;850(1-2):206-12. Epub 2006 Dec 4.

Division of Pharmaceutics, College of Pharmacy, The Ohio State University, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2006.11.027DOI Listing
May 2007

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.

Leuk Res 2007 Aug 30;31(8):1069-75. Epub 2006 Oct 30.

Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Comprehensive Cancer Center, Starling-Loving Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.09.021DOI Listing
August 2007

A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices.

Pharm Res 2006 Jun 25;23(6):1251-64. Epub 2006 May 25.

Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-006-0082-3DOI Listing
June 2006